Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

GSK-137173A

Flare of rheumatoid arthritis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Andreica I, et al. TOLERABILITY AND SAFETY OF RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES-A PROSPECTIVE LONGITUDINAL STUDY OVER 6 MONTHS. Annals of the Rheumatic Diseases 82 (Suppl. 1) : 550-551, Jun 2023. Available from: URL: http://doi.org/10.1136/annrheumdis-2023-eular.2827 [abstract] Andreica I, et al. TOLERABILITY AND SAFETY OF RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES-A PROSPECTIVE LONGITUDINAL STUDY OVER 6 MONTHS. Annals of the Rheumatic Diseases 82 (Suppl. 1) : 550-551, Jun 2023. Available from: URL: http://​doi.​org/​10.​1136/​annrheumdis-2023-eular.​2827 [abstract]
Metadaten
Titel
GSK-137173A
Flare of rheumatoid arthritis: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47937-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Paliperidone

Case report

Efavirenz

Case report

Paracetamol

Case report

Prednisolone